Peter Voorhees's guest appearances

Peter Voorhees

HealthTree Podcast for Multiple Myeloma

Heart of the City

Oncology Today with Dr Neil Love

Noopur Raje

Shaji Kumar

Natalie Callander

David Siegel

David Quinn

Mike Thompson

Philip A Philip

Beth Israel

Damian Green

Ezra Cohen

Sarah Cannon

Tom Lynch

Eric Klein

Keith Stewart

Mark Newman

OwlTail

Myeloma experts are beginning to use antibodies in earlier lines of myeloma treatment, even for newly diagnosed patients. Learn what recent clinical trials are using antibody therapies such as daratumumab and isatuximab in early quad (four) drug combinations for newly diagnosed patients. Peter Voorhees of the Levine Cancer Institute joins Myeloma Crowd Radio to share his experience and findings from these clinical trials. He will discuss the early use and their use as maintenance therapy following stem cell transplant. Is earlier use better? Should they be "saved" for later? When should patients consider using the monoclonal antibodies as maintenance therapy with or without traditional drugs like lenalidomide? Dr. Voorhees will help answer these very practical questions for the myeloma community.Thanks to our episode sponsor, Karyopharm Therapeutics.

Myeloma experts are beginning to use antibodies in earlier lines of myeloma treatment, even for newly diagnosed patients. Learn what recent clinical trials are using antibody therapies such as daratumumab and isatuximab in early quad (four) drug combinations for newly diagnosed patients. Peter Voorhees of the Levine Cancer Institute joins Myeloma Crowd Radio to share his experience and findings from these clinical trials. He will discuss the early use and their use as maintenance therapy following stem cell transplant. Is earlier use better? Should they be "saved" for later? When should patients consider using the monoclonal antibodies as maintenance therapy with or without traditional drugs like lenalidomide? Dr. Voorhees will help answer these very practical questions for the myeloma community. Thanks to our episode sponsor, Karyopharm Therapeutics.

Myeloma Crowd Radio: Peter Voorhees, MD, Levine Cancer Institute

Dr Peter Voorhees from the Levine Cancer Institute in Charlotte, North Carolina, discusses novel agents under investigation in multiple myeloma. CME information and select publications here.

Dr Peter Voorhees from the Levine Cancer Institute in Charlotte, North Carolina, discusses novel agents under investigation in multiple myeloma. CME information and select publications <a href="https://www.researchtopractice.com/OncologyTodayMMNovelAgents20" rel="nofollow" target="_blank">here</a>.

Novel Agents Under Investigation in Multiple Myeloma with Dr Peter Voorhees